Michael J. Fox Foundation for Parkinson’s Research Receives Lasker~Bloomberg Public Service Award
On Sept. 10, 2026, Lasker~Bloomberg Public Service Award honors Michael J. Fox (Michael J. Fox Foundation for Parkinson’s…
-
-
Lasker~DeBakey Clinical Medical Research Award Recognizes hemophilia A Treatment
On Sept. 9, 2026, the Albert Lasker~DeBakey Clinical Medical Research Award honored three scientists for inventing a bispecific…
-
Emmanuel Mignot and Masashi Yanagisawa Receive Albert Lasker Basic Medical Research Award
On Sept. 9, 2026, the Albert Lasker Basic Medical Research Award honors two physician scientists for the identification…
-
Unilever Investing $270 Million in Global Innovation Centre in New Haven, Connecticut
On May 28, 2026, Unilever unveiled plans to develop a new Global Innovation Centre in New Haven, Connecticut,…
-
Purdue Pharma sentenced in connection with its 2020 Plea Agreement with U.S. Department of Justice
On Apr. 28, 2026, the U.S. District Court for the District of New Jersey sentenced Purdue Pharma in…
-
Zhang Kai, Yale scientist leaves for China university
On Apr. 2, 2026, Zhang Kai, a rising cryo-electron microscopy researcher, has resigned from his tenure-track position at…
-
CDC | Diagnostics | Infectious Disease | Measles | NIH | Vaccine
Report Details health and economic repercussions of declining MMR coverage in the U.S.
On Feb. 20, 2026, a research study lead by the Yale School of Public Health shows the resurgence…
-
Rising U.S. nonmedical childhood vaccination exemption rates may portend disease resurgence
On Jan. 14, 2026, a Stanford University–led research team estimates that county-level US nonmedical exemptions to childhood vaccine…
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
On Nov. 14, 2025, A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma’s latest deal…
-
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
-
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
-
Biology | Biotechnology | Diagnostics | FDA | Imaging | Marine Science | Medical Device | Pharmaceutical
Horseshoe Crabs Break Free from Biomedical Testing
On Jul. 29, 2025, The Scientist reported that for 40 years, researchers relied on horseshoe crab blood to…
-
Purdue Pharma $7.4 billion opioid settlement wins broad support from US states
On Jun. 16, 2025, Purdue Pharma has won support from the attorneys general of 55 U.S. states and…
-
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
-
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
On Mar. 19, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
-
U.S. Supreme Court blocks Purdue Pharma bankruptcy settlement
On Jun. 27, 2024, the U.S. Supreme Court blocked OxyContin maker Purdue Pharma’s bankruptcy settlement that would have…
-
The Priestley Medal was awarded to Cato T. Laurencin
On Mar. 28, 2023, the American Chemical Society awarded The Priestley Medal to Cato T. Laurencin “to recognize distinguished…
-
$838 Million neurosciences center broke ground in Connecticut
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
-
Yale-developed vaccine offers superior protection against Omicron variants
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
-
Economic burden of Lyme disease could be nearly $1 billion annually in the U.S.
On May 23, 2022, a study reports the economic burden of Lyme disease could be nearly $1 billion…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 heroes & Remembrance
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
-
Qx Therapeutics received FDA authorization with IND for QXT-101 in phase 2 trial for patients with COVID-19 infection.
On Mar. 30, 2021, Qx Therapeutics announced that the FDA had cleared the company’s Investigational New Drug application…
-
TGen study predicted changing Lyme disease habitat across the West Coast
On Mar. 16, 2021, TGen announced a study that suggested ecosystems suitable for harboring ticks that carry debilitating…
-
Study found that children’s immune response protected against COVID-19
On Sept. 21, 2020, the first study comparing the immune responses of adults and children with COVID-19 has…
-
Biotechnology | COVID-19 | CRISPR | Diagnostics | HIV | Infectious Disease
UConn researchers validate clinical feasibility for COVID-19 testing at point of care
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
-
UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
-
Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration EUA for Treatment of Patients With Moderate COVID-1
On Aug. 28, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) expanded the Emergency Use…
-
UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
-
FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
